证券代码：300511 证券简称：雪榕生物 公告编号：2025-134 关于子公司为公司提供担保的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 一、担保情况概述 上海雪榕生物科技股份有限公司（以下简称"公司"）于2025年11月21日召开 了第六届董事会第一次会议，审议通过了《关于公司向农业发展银行申请流动资金 贷款的议案》。公司根据生产经营需要，决定向中国农业发展银行上海市奉贤区支 行（以下简称"农发银行"）申请额度不超过2,500万元（含2,500万元）的流动资金 贷款。 为支持公司的业务发展，公司全资子公司成都雪国高榕生物科技有限公司（以 下简称"成都雪榕"）以其拥有的厂房及土地使用权，为上述流动资金贷款提供抵 押担保；公司控股子公司大方雪榕生物科技有限公司（以下简称"大方雪榕"）、 全资子公司威宁雪榕生物科技有限公司（以下简称"威宁雪榕"）计划为上述流动 资金贷款提供连带责任保证担保。 本次担保属于公司控股子公司和全资子公司为母公司提供担保，且成都雪榕、 大方雪榕和威宁雪榕均已履行了其内部审批程序，根据《深圳证券交易所上市公司 自律监管指引第2 ...

上海市静安区山西北路 99 号苏河湾中心 25-28 楼 邮编：200085 25-28/F, Suhe Centre, 99 North Shanxi Road, Jing'an District, Shanghai, China 电话/Tel: +86 21 52341668 传真/Fax: +86 21 52341670 网址/Website: http://www.grandall.com.cn 关于上海雪榕生物科技股份有限公司 2025年第四次临时股东会的法律意见书 致：上海雪榕生物科技股份有限公司 国浩律师（上海）事务所（以下简称"本所"）接受上海雪榕生物科技股份有限公司（以 下简称"公司"）委托，指派本所律师出席公司 2025 年第四次临时股东会（以下简称"本次 股东会"）。本所根据《中华人民共和国证券法》（以下简称"《证券法》"）、《中华人 民共和国公司法》（以下简称"《公司法》"）、《上市公司股东会规则》（以下简称"《股 东会规则》"）等法律、法规、部门规章和规范性文件的规定，就公司本次股东会的召集与 召开程序、出席会议人员资格、召集人资格、会议表决程序和表决结果的合法性等有关法律 问题出具 ...

Core Insights - The agriculture sector experienced a decline of 0.54% on November 19, with Hainan Rubber leading the losses [1] - The Shanghai Composite Index closed at 3946.74, up 0.18%, while the Shenzhen Component Index closed at 13080.09, unchanged [1] Sector Performance - Notable gainers in the agriculture sector included: - Beidahuang (600598) with a closing price of 15.06, up 1.35%, trading volume of 373,000 shares, and a turnover of 560 million yuan [1] - Nuofushin (002215) closed at 11.55, up 1.05%, with a trading volume of 198,400 shares and a turnover of 230 million yuan [1] - Major decliners included: - Hainan Rubber (601118) closed at 5.90, down 3.28%, with a trading volume of 697,800 shares and a turnover of 413 million yuan [2] - Shennong Agriculture (300189) closed at 5.62, down 2.77%, with a trading volume of 2,051,200 shares and a turnover of 1.149 billion yuan [2] Capital Flow - The agriculture sector saw a net outflow of 202 million yuan from institutional investors, while retail investors contributed a net inflow of 228 million yuan [2] - Specific stock capital flows included: - Beidahuang (600598) had a net inflow of 27.18 million yuan from institutional investors, while retail investors contributed a net inflow of 9.57 million yuan [3] - Hainan Rubber (601118) experienced a net outflow of 4.92 million yuan from institutional investors [3]

Core Viewpoint - Snow Rong Biological announced a change in its controlling shareholder and actual controller following the transfer of shares to Shanghai Wanzihong Intelligent Technology Co., Ltd. [2] Group 1: Share Transfer Details - On November 4, 2025, Snow Rong Biological received notification from Shanghai Wanzihong regarding the transfer of a total of 31,585,362 shares from Yang Yongping and his concerted party Zhejiang Yinwan Private Fund Management Co., Ltd. - Yinwan Huayi No. 1 Private Securities Investment Fund [2] - The share transfer has been completed and registered with the China Securities Depository and Clearing Corporation Limited, Shenzhen Branch, and a Securities Transfer Registration Confirmation has been obtained [2] Group 2: Change in Control - Following the share transfer, the controlling shareholder of Snow Rong Biological has changed to Wanzihong, and the actual controller is now Mr. Jiang Zhi [2]

Core Viewpoint - Xuerong Biological announced the convening of its fifth board meeting on November 5, 2025, to discuss the early re-election of the board and the nomination of candidates for the sixth board [2] Group 1 - The board approved the proposal for early re-election and nomination of candidates for both non-independent and independent directors [2] - The controlling shareholder, Wanzhiqianhong, nominated four candidates for non-independent directors: Jiang Zhi, Wang Zhengshu, Zheng Weidong, and Li Jie [2] - Three candidates were nominated for independent directors: Jiang Dequan, Su Dongjun, and Zhang Luyang [2]

Group 1 - The core point of the article is that Xuerong Bio has undergone a change in its controlling shareholder and actual controller, with Shanghai Wanzihong Intelligent Technology Co., Ltd. becoming the new controlling shareholder [1] - The transfer of 31,585,362 shares from Yang Yongping and Zhejiang Yinwan Private Fund Management Co., Ltd. to Wanzihong has been completed and confirmed by the China Securities Depository and Clearing Corporation [1] - As of the report, Xuerong Bio's market capitalization is 4.6 billion yuan [1] Group 2 - For the year 2024, Xuerong Bio's revenue composition is heavily weighted towards the edible mushroom industry, which accounts for 98.62% of total revenue, while other businesses contribute only 1.38% [1]

Core Viewpoint - Xuerong Biological (300511.SZ) has announced a change in its controlling shareholder and actual controller following the completion of share transfer to Shanghai Wanzihong Intelligent Technology Co., Ltd. [1] Group 1: Share Transfer Details - Shanghai Wanzihong has acquired a total of 31,585,362 shares from Mr. Yang Yongping and his concerted party, Zhejiang Yinwan Private Fund Management Co., Ltd. - Yinwan Huayi No. 1 Private Securities Investment Fund [1] - The share transfer has been officially registered with the China Securities Depository and Clearing Co., Ltd. Shenzhen Branch, and a Securities Transfer Registration Confirmation has been obtained [1] Group 2: Changes in Control - The controlling shareholder of Xuerong Biological has now changed to Wanzihong, with Mr. Jiang Zhi becoming the actual controller of the company [1]

Group 1 - The company has recently completed a change in control, with the controlling shareholder changing from Yang Yongping to Wan Zihong, and the actual controller changing to Jiang Zhi [1] - To improve the governance structure, the board plans to hold an early re-election, nominating Jiang Zhi, Wang Zhengshu, and two others as candidates for the sixth non-independent directors, and Jiang Dequan and Su Dongjun as candidates for independent directors, with a term of three years starting from the approval at the fourth extraordinary general meeting of shareholders in 2025 [1] - The board has also approved a proposal to change the registered capital and amend the company's articles of association, with a decision to hold the fourth extraordinary general meeting of shareholders on November 21, 2025 [1]

上海雪榕生物科技股份有限公司 第六届董事会独立董事候选人 关于参加独立董事培训并取得独立董事资格证书的承诺函 根据《上市公司独立董事管理办法（2025年修正）》《深圳证券交易所自律 监管指引第2号——创业板上市公司规范运作》等相关规定，为更好地履行独立 董事职责，本人承诺如下： 本人将积极报名参加深圳证券交易所组织的最近一期独立董事培训，并承诺 取得深圳证券交易所认可的独立董事资格证书。 特此承诺。 承诺人：宿东君 2025年11月5日 根据上海雪榕生物科技股份有限公司（以下简称"公司"）第五届董事会第三 十五次会议决议，本人 宿东君 被提名为公司第六届董事会独立董事候选人。截 至公司2025年第四次临时股东大会通知公告日，本人尚未取得深圳证券交易所认 可的独立董事资格证书。 ...

上海雪榕生物科技股份有限公司 章 程 二○二五年十一月 目 录 第一章 总则 第二章 经营宗旨和范围 第三章 股份 第四章 股东和股东会 第五章 董事会 第六章 经理及其他高级管理人员 2 第一节 股份发行 第二节 股份增减和回购 第三节 股份转让 第一节 股东 第二节 股东会的一般规定 第三节 股东会的召集 第四节 股东会的提案与通知 第五节 股东会的召开 第六节 股东会的表决和决议 第一节 董事 第二节 董事会 第三节 独立董事 第四节 董事会专门委员会 第七章 党建 第八章 财务会计制度、利润分配和审计 第九章 通知与公告 第十一章 修改章程 第二条 公司系依照《公司法》和其他有关规定成立的股份有 限公司。公司以发起方式设立；整体变更设立股份有限公司时的发起 人为杨勇萍、余荣琳、诸焕诚、王向东、丁强、余贵成、陈建华、上 海六禾之颐投资中心（有限合伙）（以下简称"六禾之颐"）、德州 均益投资合伙企业（有限合伙）（以下简称"均益投资"）、上海祥 禾泓安股权投资合伙企业（有限合伙）（以下简称"祥禾泓安"）和 天津天图兴华股权投资合伙企业（有限合伙）（以下简称"天图兴华"）； 公司实行自主经营、独立核算、自负盈 ...